Skip to content

Retrospective Analysis of Spray Skin Treats for Severe Burns

A Real-world 10-year Single Center Experience With Spray Skin in the Treatment of Extensive Severe Burns

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06170424
Enrollment
85
Registered
2023-12-14
Start date
2012-01-01
Completion date
2022-12-31
Last updated
2023-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morality, Skin Graft Complications

Keywords

spray skin, severe burn, microskin grafting

Brief summary

This study investigated the efficacy of novel approach spray skin for extensive severe burns treatment.

Detailed description

Burns are a global public health problem. This study investigated the efficacy of novel approach spray skin (autologous skin cell suspension combined with split-thickness skin grafting, STSG) for extensive severe burns treatment. We performed a real-world retrospective analysis of extensive burns patients (\> 50% TBSA) from our hospital last 10 years.

Interventions

PROCEDUREspray skin

The patients who used the autologous skin cell suspension combined with skin grafting.

PROCEDUREControl group

The patients who used skin grafting.

Sponsors

First Affiliated Hospital, Sun Yat-Sen University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patients with \> 50% TBSA

Exclusion criteria

* died within 1 week after admission * admitted to hospital more than 1 week after injury

Design outcomes

Primary

MeasureTime frameDescription
survival ratethrough study completion, an average of 1 yearPatient survival during hospitalization

Secondary

MeasureTime frameDescription
complication of skin graftthe take rate in the postoperative day 30, 60, 90the survival of grafting skin
length of hospitalthrough study completion, usually no more than 6 monthsThe time during which the patient was hospitalized

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026